TREOSULFAN- VERSUS BUSULFAN-BASED CONDITIONING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME: A SINGLE-CENTRE RETROSPECTIVE PROPENSITY SCORE-MATCHED COHORT STUDY

被引：0
|
作者：
Moya, Tommy Alfaro [1 ,2 ]
Remberger, Mats [3 ]
Chen, Carol [1 ]
Gerbitz, Armin [1 ,2 ]
Kim, Dennis Dong Hwan [1 ,2 ]
Kumar, Rajat [1 ,2 ]
Lam, Wilson [1 ,2 ]
Law, Arjun Datt [1 ,2 ]
Lipton, Jeffrey H. [1 ,2 ]
Michelis, Fotios V. [1 ,2 ]
Basso, Igor Novitzky [1 ,2 ]
Viswabandya, Auro [1 ,2 ]
Mattsson, Jonas [1 ,2 ]
Pasic, Ivan [1 ,2 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Uppsala Hosp, Uppsala, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O060
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [1] Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study
    Pasic, Ivan
    Moya, Tommy Alfaro
    Remberger, Mats
    Chen, Carol
    Gerbitz, Armin
    Kim, Dennis Dong Hwan
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun Datt
    Lipton, Jeffrey H.
    Michelis, Fotios, V
    Novitzky-Basso, Igor
    Viswabandya, Auro
    Mattsson, Jonas
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (07): : 681.e1 - 681.e11
  • [2] Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis
    Shuhei Kurosawa
    Yoshimitsu Shimomura
    Hidehiro Itonaga
    Yuho Najima
    Takeshi Kobayashi
    Yukiyasu Ozawa
    Yoshinobu Kanda
    Shinichi Kako
    Toshiro Kawakita
    Ken-ichi Matsuoka
    Yumiko Maruyama
    Shuichi Ota
    Hideyuki Nakazawa
    Kazunori Imada
    Junya Kanda
    Takahiro Fukuda
    Yoshiko Atsuta
    Jun Aoki
    Bone Marrow Transplantation, 2021, 56 : 3008 - 3015
  • [3] Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis
    Kurosawa, Shuhei
    Shimomura, Yoshimitsu
    Itonaga, Hidehiro
    Najima, Yuho
    Kobayashi, Takeshi
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Kako, Shinichi
    Kawakita, Toshiro
    Matsuoka, Ken-ichi
    Maruyama, Yumiko
    Ota, Shuichi
    Nakazawa, Hideyuki
    Imada, Kazunori
    Kanda, Junya
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Aoki, Jun
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 3008 - 3015
  • [4] Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study
    Saglio, Francesco
    Pagliara, Daria
    Zecca, Marco
    Balduzzi, Adriana
    Cattoni, Alessandro
    Prete, Arcangelo
    Tambaro, Francesco Paolo
    Faraci, Maura
    Calore, Elisabetta
    Locatelli, Franco
    Fagioli, Franca
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 433.e1 - 433.e10
  • [5] Graft-versus-host disease (GVHD) and GVHD-free/relapse-free survival (GRFS) in patients with myelodysplastic syndrome (MDS) after treosulfan- versus busulfan-based conditioning and allogeneic hematopoietic cell transplantation (alloHCT)
    Stelljes, M.
    Trenschel, R.
    Beelen, D.
    Markiewicz, M.
    Wagner-Drouet, E-M
    Bethge, W.
    Remenyi, P.
    Niederwieser, D.
    Grigoleit, G. U.
    Schaefer-Eckart, K.
    Stoelzel, F.
    Ciceri, F.
    Dreger, P.
    Junghanss, C.
    Holler, E.
    Rambaldi, A.
    Russo, D.
    Verbeek, M.
    Casper, J.
    Patriarca, F.
    Bieniaszewska, M.
    Glass, B.
    Scheid, C.
    Basara, N.
    Finke, J.
    Hilgendorf, I.
    Labussiere-Wallet, H.
    Stuhler, G.
    Schroeder, T.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 37 - 37
  • [6] Treosulfan- Versus Busulfan-Based Myeloablative Conditioning For Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia. A Report From The International AllSCTPED Forum Trial
    Pichler, Herbert
    Dalle, Jean-Hugues
    Locatelli, Franco
    Poetschger, Ulrike
    Sedlacek, Petr
    Buechner, Jochen
    Shaw, Peter J.
    Staciuk, Raquel
    Ifversen, Marianne
    Vettenranta, Kim
    Svec, Peter
    Aleinikova, Olga
    Stein, Jerry
    Gungor, Tayfun
    Toporski, Jacek
    Truong, Tony H.
    Diaz-de-Heredia, Cristina
    Bierings, Marc
    Ariffin, Hany
    Essa, Mohammed
    Burkhardt, Birgit
    Schultz, Kirk
    Meisel, Roland
    Lankester, Arjan
    Ansari, Marc
    Schrappe, Martin
    von Stackelberg, Arend
    Balduzzi, Adriana
    Corbacioglu, Selim
    Bader, Peter
    Peters, Christina
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 163 - 164
  • [7] Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis
    Kurosawa, Shuhei
    Shimomura, Yoshimitsu
    Itonaga, Hidehiro
    Najima, Yuho
    Kobayashi, Takeshi
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Kako, Shinichi
    Kawakita, Toshiro
    Matsuoka, Ken-ichi
    Maruyama, Yumiko
    Ota, Shuichi
    Nakazawa, Hideyuki
    Imada, Kazunori
    Kimura, Takafumi
    Kanda, Junya
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Ishiyama, Ken
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (06): : 323.e1 - 323.e9
  • [8] Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndrome: A Propensity Score-Matched Retrospective Cohort Study Using Trinetx
    Waris, Shanawar
    Saifuddin, Adnan
    Thakkar, Yashan
    Monroe, Gary
    Fatima, Zainab
    Shultz, Carl
    Safi, Danish
    Safi, Salah Ud Din
    BLOOD, 2024, 144 : 4603 - 4604
  • [9] TREOSULFAN VERSUS BUSULFAN-BASED CONDITIONING REGIMENS FOR FIRST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN CHILDREN WITH ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: A RETROSPECTIVE PDWP/ EBMT STUDY
    Rangarajan, Hemalatha G.
    Perez Martinez, Antonio
    Galimard, Jacques-Emmanuel
    Dalissier, Arnaud
    Hamladji, Rose-Marie
    Mirci-Danicar, Oana
    Locatelli, Franco
    Mielcarek-Siedziuk, Monika
    Balduzzi, Adriana
    Styczynski, Jan
    Fagioli, Franca
    Renard, Cecile
    Dalle, Jean Hugues
    Ayas, Mouhab
    Buechner, Jochen
    Ifversen, Marianne
    Sedlacek, Petr
    Rao, Kanchan
    Wynn, Robert
    Ansari, Marc
    Kleinschmidt, Katharina
    Kalwak, Krzysztof
    BONE MARROW TRANSPLANTATION, 2024, 59 : 61 - 62
  • [10] Long-Term Outcomes of Treosulfan- vs. Busulfan-Based Conditioning Regimen for Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia Before Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
    Zhu, Sheng
    Liu, Gang
    Liu, Jing
    Chen, Qiuying
    Wang, Zhiqiang
    FRONTIERS IN ONCOLOGY, 2020, 10
12345